277 related articles for article (PubMed ID: 23732806)
1. Novel gel-niosomes formulations as multicomponent systems for transdermal drug delivery.
Tavano L; Gentile L; Oliviero Rossi C; Muzzalupo R
Colloids Surf B Biointerfaces; 2013 Oct; 110():281-8. PubMed ID: 23732806
[TBL] [Abstract][Full Text] [Related]
2. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
3. Liquid crystalline Pluronic 105 pharmacogels as drug delivery systems: preparation, characterization, and in vitro transdermal release.
Muzzalupo R; Tavano L; Nicoletta FP; Trombino S; Cassano R; Picci N
J Drug Target; 2010 Jun; 18(5):404-11. PubMed ID: 20021229
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
5. Niosomes containing hydroxyl additives as percutaneous penetration enhancers: effect on the transdermal delivery of sulfadiazine sodium salt.
Muzzalupo R; Tavano L; Lai F; Picci N
Colloids Surf B Biointerfaces; 2014 Nov; 123():207-12. PubMed ID: 25260220
[TBL] [Abstract][Full Text] [Related]
6. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems.
Muzzalupo R; Tavano L; Cassano R; Trombino S; Ferrarelli T; Picci N
Eur J Pharm Biopharm; 2011 Sep; 79(1):28-35. PubMed ID: 21303691
[TBL] [Abstract][Full Text] [Related]
7. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
8. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
Tavano L; Alfano P; Muzzalupo R; de Cindio B
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
[TBL] [Abstract][Full Text] [Related]
9. Niosomes from glucuronic acid-based surfactant as new carriers for cancer therapy: preparation, characterization and biological properties.
Tavano L; Aiello R; Ioele G; Picci N; Muzzalupo R
Colloids Surf B Biointerfaces; 2014 Jun; 118():7-13. PubMed ID: 24709252
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
11. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
[TBL] [Abstract][Full Text] [Related]
12. Niosomes from alpha,omega-trioxyethylene-bis(sodium 2-dodecyloxy-propylenesulfonate): preparation and characterization.
Muzzalupo R; Tavano L; Trombino S; Cassano R; Picci N; La Mesa C
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):200-7. PubMed ID: 18378125
[TBL] [Abstract][Full Text] [Related]
13. Characterization and skin permeation of ketoprofen-loaded vesicular systems.
Uchino T; Lefeber F; Gooris G; Bouwstra J
Eur J Pharm Biopharm; 2014 Feb; 86(2):156-66. PubMed ID: 23500115
[TBL] [Abstract][Full Text] [Related]
14. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
15. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
17. Sodium dodecyl sulfate improved stability and transdermal delivery of salidroside-encapsulated niosomes via effects on zeta potential.
Zhang Y; Jing Q; Hu H; He Z; Wu T; Guo T; Feng N
Int J Pharm; 2020 Apr; 580():119183. PubMed ID: 32112930
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin loaded magneto-niosomes for targeted drug delivery.
Tavano L; Vivacqua M; Carito V; Muzzalupo R; Caroleo MC; Nicoletta F
Colloids Surf B Biointerfaces; 2013 Feb; 102():803-7. PubMed ID: 23107959
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone.
Shah P; Goodyear B; Dholaria N; Puri V; Michniak-Kohn B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546426
[TBL] [Abstract][Full Text] [Related]
20. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients.
Kandil SM; Soliman II; Diab HM; Bedair NI; Mahrous MH; Abdou EM
Drug Deliv; 2022 Dec; 29(1):534-547. PubMed ID: 35156490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
